Back to results
US 9,540,340 B2Granted
3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-3-deutero-piperidine-2,6-dione derivatives and compositions comprising and methods of using the same
AssigneeDeuteRx, LLC
InventorSheila DeWitt
Life of this patent
Estimating the term…
Abstract
The invention provides 3-deuterium-enriched 3-(5-substituted-4-oxoquinazolin-3(4H)-yl)-piperidine-2,6-diones, deuterated derivatives thereof, stereoisomers thereof, pharmaceutically acceptable salt forms thereof, and methods of treatment using the same, such as in the treatment of cancer, an immune-related disease, or an inflammatory disease.
Claims4
A deuterium-enriched compound represented by:
- having an enantiomeric excess of at least 90%, or a pharmaceutically acceptable salt thereof;
- wherein:
- Z is D.
Dependencies are inferred from the claim text.